Auto BMT for Non-M3 AML in 1st Remission in Pts </=60y of Age Using Busulfan/FTBI & VP16 as a Prep R
City of Hope Medical Center
City of Hope Medical Center
Thomas Jefferson University
Stanford University
Eastern Cooperative Oncology Group
Masonic Cancer Center, University of Minnesota
National Cancer Institute (NCI)
Virginia Commonwealth University
Masonic Cancer Center, University of Minnesota
Eastern Cooperative Oncology Group
Roswell Park Cancer Institute
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Rutgers, The State University of New Jersey
Masonic Cancer Center, University of Minnesota
Children's Oncology Group
H. Lee Moffitt Cancer Center and Research Institute
Fred Hutchinson Cancer Center
Case Comprehensive Cancer Center
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)
Nohla Therapeutics, Inc.
Case Comprehensive Cancer Center
Stanford University
M.D. Anderson Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Cancer Institute (NCI)
Wake Forest University Health Sciences
National Cancer Institute (NCI)
University of Washington
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)
Fred Hutchinson Cancer Center
Gruppo Italiano Malattie EMatologiche dell'Adulto
National Cancer Institute (NCI)
Wake Forest University Health Sciences
Children's Oncology Group
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Case Comprehensive Cancer Center
City of Hope Medical Center
National Cancer Institute (NCI)
Alliance for Clinical Trials in Oncology
Children's Oncology Group
SWOG Cancer Research Network
King Faisal Specialist Hospital & Research Center
Asan Medical Center
Case Comprehensive Cancer Center
National Cancer Institute (NCI)